Title  | Date  | Price |
|---|
Premium Company Profile CV Therapeutics
| Oct 2007 |
£300 |
Premium Company Profile WeightWatchers International, Inc.
| Oct 2007 |
£300 |
Premium Company Profile Perot Systems Corporation
| Oct 2007 |
£300 |
Premium Company Profile ImmunoGen
| Oct 2007 |
£300 |
Premium Company Profile - CuraGen
| Oct 2007 |
£300 |
Premium Company Profile - Sunesis Pharmaceuticals
| Oct 2007 |
£300 |
Premium Company Profile - Altus Pharmaceuticals
| Oct 2007 |
£300 |
Premium Company Profile CollaGenex
| Oct 2007 |
£300 |
Premium Company Profile Santarus
| Oct 2007 |
£300 |
Premium Company Profile Savient Pharmaceuticals
| Oct 2007 |
£300 |
Premium Company Profile - Genmab
| Oct 2007 |
£300 |
Premium Company Profile Gedeon Richter
| Oct 2007 |
£300 |
Premium Company Profile Celgene
| Oct 2007 |
£300 |
Premium Company Profile - Amylin Pharmaceuticals
| Oct 2007 |
£300 |
Premium Company Profile Barrier Therapeutics
| Oct 2007 |
£300 |
Premium Company Profile Dyax
| Oct 2007 |
£300 |
Premium Company Profile Cytogen
| Oct 2007 |
£300 |
Premium Company Profile Medarex
| Oct 2007 |
£300 |
Premium Company Profile ImClone Systems
| Oct 2007 |
£300 |
Premium Company Profile - Human Genome Sciences
| Oct 2007 |
£300 |
Premium Company Profile - Elan Corporation plc
| Oct 2007 |
£300 |
Chugai: Pharmavitae Profile 2007
| Oct 2007 |
£3,425 |
Roche: Pharmavitae Profile
| Oct 2007 |
£3,425 |
Dade Behring Inc. - SWOT Analysis
| Oct 2007 |
£75 |
In Vitro Diagnostic Companies Analysis
| Sep 2007 |
£595 |
Watson
Pharmavitae Generics Profile
| Sep 2007 |
£2,280 |
MedImmune, Inc. - SWOT Analysis
| Sep 2007 |
£75 |
Sanofi-aventis: Pipeline, Products, Performance, Potential
| Sep 2007 |
£595 |
Company Study of Guangxi Wuzhou Zhongheng Group Co., Ltd., 2007
| Aug 2007 |
£210 |
PharmaVitae Generics - Teva
| Jul 2007 |
£2,280 |
Kyowa Hakko Kogyo Co., Ltd. - SWOT Analysis
| Jul 2007 |
£75 |
Pharmion Corporation - SWOT Analysis
| Jul 2007 |
£75 |
Johnson&Johnson IMS Company Profile
| Jul 2007 |
£510 |
Global - Services - E-health
| Jun 2007 |
£24 |
CompanyStudyofJiangsuHengruiMedicineCo
Ltd.,2007
| Jun 2007 |
£210 |
Biovail IMS Company Profile
| Jun 2007 |
£249 |
Edwards Lifesciences Medical Device Company Intelligence Report
| Jun 2007 |
£295 |
Tanabe Seiyaku Co., Ltd. - SWOT Analysis
| May 2007 |
£75 |
Sabinsa case study: successfully marketing weight-loss supplements
| May 2007 |
£175 |
ALZA Corporation - SWOT Analysis
| May 2007 |
£75 |
Triad Hospitals, Inc. - SWOT Analysis
| May 2007 |
£75 |
Pharmaceuticals
2006 Fortune Global 500 Company Profiles
| Apr 2007 |
£55 |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
| Apr 2007 |
£1,499 |
Financial Analysis - CVS Corporation
| Apr 2007 |
£240 |
Ipsen
PharmaVitae Profile
| Mar 2007 |
£3,425 |
Bracco
Company Profile
| Feb 2007 |
£1,200 |
Guerbet
Company Profile
| Feb 2007 |
£1,200 |
Toshiba
Company Profile
| Feb 2007 |
£1,200 |
Philips Medical Systems: Company Profile
| Feb 2007 |
£1,200 |
Servier
PharmaVitae Profile
| Feb 2007 |
£3,425 |
Cardinal Health
Company Profile
| Feb 2007 |
£1,200 |
Millennium: PharmaVitae Profile
| Feb 2007 |
£3,425 |
Top 200 Indian Pharma Company Profiles
| Feb 2007 |
£550 |
Gilead
PharmaVitae Profile
| Jan 2007 |
£3,425 |
GlaxoSmithKline: PharmaVitae Profile
| Jan 2007 |
£3,425 |
Novartis
PharmaVitae Profile
| Jan 2007 |
£3,425 |
GlaxoSmithKline
PharmaVitae Profile
| Jan 2007 |
£3,425 |
Merck Serono Biopharmaceuticals
PharmaVitae Profile
| Jan 2007 |
£3,425 |
Endo Pharmaceuticals IMS Company Profile
| Jan 2007 |
£249 |
Daiichi Sankyo
PharmaVitae Profile
| Dec 2006 |
£3,425 |
Abbott
PharmaVitae Profile
| Dec 2006 |
£3,425 |
Chiron
PharmaVitae Profile
| Dec 2006 |
£3,425 |
The Pharmaceutical Company Outlook to 2011
Financial and Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
| Dec 2006 |
£4,570 |
Applied Biosystems Group
| Dec 2006 |
£185 |
Schering AG
PharmaVitae Profile
| Dec 2006 |
£3,425 |
Bayer Schering Pharma
PharmaVitae Profile
| Dec 2006 |
£3,425 |
Serono IMS Company Profile
| Dec 2006 |
£510 |
3M IMS Company Profile
| Dec 2006 |
£249 |
Nycomed IMS Company Profile
| Dec 2006 |
£510 |
Pierre Fabre
PharmaVitae Profile
| Nov 2006 |
£3,425 |
Genzyme
PharmaVitae Profile
| Nov 2006 |
£3,425 |
Lundbeck
PharmaVitae Profile
| Nov 2006 |
£3,425 |
Meji Seika IMS Company Profile
| Nov 2006 |
£249 |
Schering AG IMS Company Profile
| Nov 2006 |
£249 |
Shire
PharmaVitae Profile
| Oct 2006 |
£3,425 |
Recordati
PharmaVitae Profile
| Oct 2006 |
£3,425 |
Forest Laboratories
PharmaVitae Profile
| Oct 2006 |
£3,425 |
AstraZeneca
PharmaVitae Profile
| Oct 2006 |
£3,425 |
Novo Nordisk
PharmaVitae Profile
| Oct 2006 |
£3,425 |
Serono
PharmaVitae Profile
| Oct 2006 |
£3,425 |
Takeda
PharmaVitae Profile
| Oct 2006 |
£3,425 |
Altana
PharmaVitae Profile
| Sep 2006 |
£3,425 |
Schering-Plough
PharmaVitae Profile
| Sep 2006 |
£3,425 |
Akzo Nobel/Organon
PharmaVitae Profile
| Sep 2006 |
£3,425 |
MedImmune
PharmaVitae Profile
| Sep 2006 |
£3,425 |
Snapshots Aetna, Inc. 2006
| Jun 2006 |
£45 |
Snapshots UnitedHealth Group, Inc. 2006
| Jun 2006 |
£45 |
Johnson & Johnson Inc
| Feb 2006 |
£195 |
Affymetrix, Inc. and Microarrays
| Jan 2006 |
£185 |
The Top 50 Pharmaceutical Manufacturing Companies In Ireland
| Sep 2005 |
£300 |
Amgen
Profile, Patents and Pipeline
| Aug 2005 |
£300 |
Actelion Ltd: PharmaVitae Profile
| Jan 1970 |
£3,475 |
first
previous
